ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

161

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

November 27, 2024

Study Completion Date

December 31, 2025

Conditions

Colorectal Cancer

Interventions

DRUG

Aspirin

Capsule taken orally

OTHER

Placebo

Capsule taken orally

Trial Locations (1)

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Massachusetts General Hospital

OTHER